• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Positive airway pressure longer than 24 h is associated with histopathological volutrauma in severe COVID-19 pneumonia-an ESGFOR based narrative case-control review.持续气道正压通气超过24小时与重症新型冠状病毒肺炎的组织病理学容积伤相关——一项基于ESGFOR的叙述性病例对照研究。
Ann Transl Med. 2022 Jun;10(11):644. doi: 10.21037/atm-22-605.
2
Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID-19 pneumonia in Wuhan, China.中国武汉一系列 30 例微创尸检 COVID-19 肺炎患者中弥漫性肺泡损伤向纤维性进展。
Histopathology. 2021 Mar;78(4):542-555. doi: 10.1111/his.14249. Epub 2020 Nov 11.
3
Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD.新型冠状病毒疾病 2019 感染导致的弥漫性肺泡损伤(DAD)在形态上与其他 DAD 病因无法区分。
Histopathology. 2020 Oct;77(4):570-578. doi: 10.1111/his.14180. Epub 2020 Sep 12.
4
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
5
[Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].严重急性呼吸综合征与2019冠状病毒病的临床和病理特征比较
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jun 12;43(6):496-502. doi: 10.3760/cma.j.cn112147-20200311-00312.
6
Diffuse alveolar damage of the lungs in forensic autopsies: assessment of histopathological stages and causes of death.法医尸检中肺的弥漫性肺泡损伤:组织病理学分期及死因评估
ScientificWorldJournal. 2012;2012:657316. doi: 10.1100/2012/657316. Epub 2012 Sep 17.
7
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
8
Postmortem lung biopsies from four patients with COVID-19 at a tertiary hospital in Cape Town, South Africa.南非开普敦一家三级医院的 4 名 COVID-19 患者的死后肺活检。
S Afr Med J. 2020 Oct 19;110(12):1195-1200. doi: 10.7196/SAMJ.2020.v110i12.15290.
9
Postmortem Cardiopulmonary Pathology in Patients with COVID-19 Infection: Single-Center Report of 12 Autopsies from Lausanne, Switzerland.新型冠状病毒肺炎感染患者的尸检心肺病理学:来自瑞士洛桑的12例尸检单中心报告
Diagnostics (Basel). 2021 Jul 28;11(8):1357. doi: 10.3390/diagnostics11081357.
10
Tracking the time course of pathological patterns of lung injury in severe COVID-19.追踪严重 COVID-19 中肺损伤的病理模式的时间进程。
Respir Res. 2021 Jan 29;22(1):32. doi: 10.1186/s12931-021-01628-9.

引用本文的文献

1
Understanding COVID-19-associated endothelial dysfunction: role of PIEZO1 as a potential therapeutic target.了解 COVID-19 相关的血管内皮功能障碍:PIEZO1 作为潜在治疗靶点的作用。
Front Immunol. 2024 Feb 29;15:1281263. doi: 10.3389/fimmu.2024.1281263. eCollection 2024.
2
Histopathologic evidence of ventilator-induced lung injury in COVID-19.新型冠状病毒肺炎中呼吸机相关性肺损伤的组织病理学证据
Ann Transl Med. 2022 Sep;10(18):949. doi: 10.21037/atm-22-4153.

本文引用的文献

1
Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study.社区获得性肺炎和 COVID-19 患者血栓事件和死亡率的比较:一项多中心观察性研究。
Thromb Haemost. 2022 Feb;122(2):257-266. doi: 10.1055/a-1692-9939. Epub 2021 Dec 29.
2
Role of total lung stress on the progression of early COVID-19 pneumonia.全肺应力在早期 COVID-19 肺炎进展中的作用。
Intensive Care Med. 2021 Oct;47(10):1130-1139. doi: 10.1007/s00134-021-06519-7. Epub 2021 Sep 16.
3
Pulmonary pathology of COVID-19: a review of autopsy studies.新型冠状病毒肺炎的肺部病理学:尸检研究综述
Curr Opin Pulm Med. 2021 May 1;27(3):184-192. doi: 10.1097/MCP.0000000000000761.
4
Characteristics of SARS-CoV-2 and COVID-19.SARS-CoV-2 和 COVID-19 的特征。
Nat Rev Microbiol. 2021 Mar;19(3):141-154. doi: 10.1038/s41579-020-00459-7. Epub 2020 Oct 6.
5
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020).《COVID-19 管理指南更新:美国胸科学会/欧洲呼吸学会协调的国际工作组(2020 年 7 月 29 日)》
Eur Respir Rev. 2020 Oct 5;29(157). doi: 10.1183/16000617.0287-2020. Print 2020 Sep 30.
6
Evidence for systematic autopsies in COVID-19 positive deceased: Case report of the first German investigated COVID-19 death.COVID-19阳性死者进行系统尸检的证据:首例德国调查的COVID-19死亡病例报告。
Rechtsmedizin (Berl). 2020;30(3):184-189. doi: 10.1007/s00194-020-00401-4. Epub 2020 May 25.
7
Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients.COVID-19 患者存在多器官病毒传播,但死后未发现特异性发现。
Crit Care. 2020 Aug 12;24(1):495. doi: 10.1186/s13054-020-03218-5.
8
Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy.严重急性呼吸综合征冠状病毒2:从基因结构到致病机制及潜在治疗方法
Front Microbiol. 2020 Jul 3;11:1576. doi: 10.3389/fmicb.2020.01576. eCollection 2020.
9
SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.严重急性呼吸综合征冠状病毒 2 感染相关性噬血细胞性淋巴组织细胞增生症。
Am J Clin Pathol. 2020 Sep 8;154(4):466-474. doi: 10.1093/ajcp/aqaa124.
10
Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain.西班牙首例已知的严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)死亡病例的尸检结果。
Rev Esp Patol. 2020 Jul-Sep;53(3):188-192. doi: 10.1016/j.patol.2020.04.002. Epub 2020 May 11.

持续气道正压通气超过24小时与重症新型冠状病毒肺炎的组织病理学容积伤相关——一项基于ESGFOR的叙述性病例对照研究。

Positive airway pressure longer than 24 h is associated with histopathological volutrauma in severe COVID-19 pneumonia-an ESGFOR based narrative case-control review.

作者信息

Saegeman Veroniek, Cohen Marta C, Abasolo Lydia, Rello Jordi, Fernandez-Gutierrez Benjamin, Fernandez-Rodriguez Amparo

机构信息

Department of Microbiology and Infection Control, Vitaz, Sint-Niklaas, Belgium.

Department of Infection Control, University Hospitals, Leuven, Belgium.

出版信息

Ann Transl Med. 2022 Jun;10(11):644. doi: 10.21037/atm-22-605.

DOI:10.21037/atm-22-605
PMID:35813341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9263787/
Abstract

BACKGROUND AND OBJECTIVE

A thorough understanding of the pathogenic mechanisms elicited by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still requires further research. Until recently, only a restricted number of autopsies have been performed, therefore limiting the accurate knowledge of the lung injury associated with SARS-CoV-2. A multidisciplinary European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group of Forensic and Post-mortem Microbiology-ESGFOR team conducted a non-systematic narrative literature review among coronavirus 2019 disease (COVID-19) pneumonia cases assessing the histopathological (HP) effects of positive airways pressure. HP lung features were recorded and compared between mechanically ventilated (>24 hours) and control (ventilation <24 hours) patients. A logistic regression analysis was performed to identify associations between mechanical ventilation (MV) and HP findings.

METHODS

A PubMed and MEDLINE search was conducted in order to identify studies published between March 1st 2020 and June 30th 2021.

KEY CONTENT AND FINDINGS

Seventy patients (median age: 69 years) from 24 studies were analysed, among whom 38 (54.2%) underwent MV longer than 24 hours. Overall, main HP features were: diffuse alveolar damage (DAD) in 53 (75.7%), fibrosis (interstitial/intra-alveolar) in 43 (61.4%), vascular damage-including thrombosis/emboli- in 41 (58.5%), and endotheliitis in only 8 (11.4%) patients. Association of DAD, fibrosis and vascular damage was detected in 30 (42.8%) patients. Multivariate analysis, adjusted by age and gender, identified MV >24 hours as an independent variable associated with DAD (OR =5.40, 95% CI: 1.48-19.62), fibrosis (OR =3.88, 95% CI: 1.25-12.08), vascular damage (OR =5.49, 95% CI: 1.78-16.95) and association of DAD plus fibrosis plus vascular damage (OR =6.99, 95% CI: 2.04-23.97).

CONCLUSIONS

We identified that patients mechanically ventilated >24 hours had a significantly higher rate of pulmonary injury on histopathology independently of age and gender. Our findings emphasize the importance of maintaining a protective ventilator strategy when subjects with COVID-19 pneumonia undergo intubation.

摘要

背景与目的

全面了解严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发的致病机制仍需进一步研究。直到最近,仅进行了数量有限的尸检,因此限制了对与SARS-CoV-2相关的肺损伤的准确认识。欧洲临床微生物学和传染病学会(ESCMID)法医与尸检微生物学多学科研究小组-ESGFOR团队对2019冠状病毒病(COVID-19)肺炎病例进行了非系统性叙述性文献综述,评估气道正压通气的组织病理学(HP)影响。记录并比较了机械通气时间>24小时的患者和对照组(通气时间<24小时)患者的HP肺部特征。进行了逻辑回归分析,以确定机械通气(MV)与HP结果之间的关联。

方法

在PubMed和MEDLINE上进行检索,以识别2020年3月1日至2021年6月三十日期间发表的研究。

关键内容与发现

对来自24项研究的70例患者(中位年龄:69岁)进行了分析,其中38例(54.2%)接受了超过24小时的MV。总体而言,主要的HP特征为:53例(75.7%)出现弥漫性肺泡损伤(DAD),43例(61.4%)出现纤维化(间质/肺泡内),41例(58.5%)出现血管损伤,包括血栓形成/栓子,仅8例(11.4%)患者出现内皮炎。30例(42.8%)患者检测到DAD、纤维化和血管损伤相关联。经年龄和性别校正的多变量分析确定,MV>24小时是与DAD(比值比=5.40,95%置信区间:1.48-19.62)、纤维化(比值比=3.88,95%置信区间:1.25-12.08)、血管损伤(比值比=5.49,95%置信区间:1.78-16.95)以及DAD加纤维化加血管损伤相关联(比值比=6.99,95%置信区间:2.04-23.97)的独立变量。

结论

我们发现,机械通气>24小时的患者在组织病理学上出现肺部损伤的发生率显著更高,且与年龄和性别无关。我们的研究结果强调了COVID-19肺炎患者插管时维持保护性通气策略的重要性。